Company Filing History:
Years Active: 2022
Title: Urpo Juhani Lamminmäki: Innovator in Antibody Polypeptides
Introduction
Urpo Juhani Lamminmäki is a notable inventor based in Vanhalinna, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of antibody polypeptides. His work focuses on innovative solutions for medical diagnostics and treatments.
Latest Patents
Lamminmäki holds a patent for "Antibody polypeptides and uses thereof." This invention provides antibody polypeptides with binding specificity for prostate-specific antigen (PSA). The patent details that the antibody polypeptide comprises a heavy chain variable region and a light chain variable region, which include specific amino acid sequences. The invention further outlines the use of these antibody polypeptides in the diagnosis and treatment of prostate cancer.
Career Highlights
Throughout his career, Lamminmäki has demonstrated a commitment to advancing medical science. His innovative approach has led to the development of valuable therapeutic tools that can improve patient outcomes in cancer treatment. He is associated with Fredax Ab, where he continues to contribute to research and development in biotechnology.
Collaborations
Lamminmäki has worked alongside talented colleagues, including Amanda Thuy Tran and Anders Axelsson. Their collaborative efforts have fostered a productive environment for innovation and research.
Conclusion
Urpo Juhani Lamminmäki is a distinguished inventor whose work in antibody polypeptides has the potential to make a significant impact in the field of prostate cancer diagnosis and treatment. His contributions reflect the importance of innovation in medical science.